chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Creatinine renal clearance decreased, Death, Dyspnoea, Dyspnoea exertional, Fatigue
Clinical narrative: Patient arrived to Medical Center on 09/07/2021 for generalized weakness, chronic back pain, feeling tired and fatigued.  Additionally, patient reports having nonproductive cough, sore throat, mild shortness of breath for about 2-3 weeks. She reports being vaccinated for COVID-19 in March 202t with Pfizer. She was tested positive for COVID-19 on admission. Chest x-ray showed developing left lower lobe pneumonia. She received Zosyn in the ED however antibiotics were deferred after admission since her procalcitonin was negative, and no significant leukocytosis was noted. She was placed on nasal cannula at 2 L, and started on Decadron. Cardiology was consulted to recommend regarding her cardioprotective agents that she does not want to take.  CT chest PE protocol was deferred since her D-dimer was mildly elevated and considered within normal limit for her age. Patient did not qualify for remdesivir secondary to low creatinine clearance.  On 09/09/2021, her oxygen requirement went up, and she was requiring 8 L nasal cannula to maintain saturations low 90s at rest and was having dyspnea exertion with ambulation. Due to increased 02 requirement, she was changed from Decadron to IV Solu-Medrol frequently, and also started on Baricitinib. Chest x-ray from 09/09/2021 showed patchy infiltrates and/or edema slightly worsened therefore she was given a dose of Lasix x1. She was seen by Cardiology and setting was okay for her to not continue her Entresto if the patient wishes not to take the medication. Alternative, Cardiology recommended starting the patient on low-dose ACE-inhibitor therefore she was started on low-dose lisinopril.  Family decided on palliative care; patient expired on 09/17/2021.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer normal, Lung infiltration, Oropharyngeal pain, Pneumonia, Procalcitonin normal
Clinical narrative: Patient arrived to Medical Center on 09/07/2021 for generalized weakness, chronic back pain, feeling tired and fatigued.  Additionally, patient reports having nonproductive cough, sore throat, mild shortness of breath for about 2-3 weeks. She reports being vaccinated for COVID-19 in March 202t with Pfizer. She was tested positive for COVID-19 on admission. Chest x-ray showed developing left lower lobe pneumonia. She received Zosyn in the ED however antibiotics were deferred after admission since her procalcitonin was negative, and no significant leukocytosis was noted. She was placed on nasal cannula at 2 L, and started on Decadron. Cardiology was consulted to recommend regarding her cardioprotective agents that she does not want to take.  CT chest PE protocol was deferred since her D-dimer was mildly elevated and considered within normal limit for her age. Patient did not qualify for remdesivir secondary to low creatinine clearance.  On 09/09/2021, her oxygen requirement went up, and she was requiring 8 L nasal cannula to maintain saturations low 90s at rest and was having dyspnea exertion with ambulation. Due to increased 02 requirement, she was changed from Decadron to IV Solu-Medrol frequently, and also started on Baricitinib. Chest x-ray from 09/09/2021 showed patchy infiltrates and/or edema slightly worsened therefore she was given a dose of Lasix x1. She was seen by Cardiology and setting was okay for her to not continue her Entresto if the patient wishes not to take the medication. Alternative, Cardiology recommended starting the patient on low-dose ACE-inhibitor therefore she was started on low-dose lisinopril.  Family decided on palliative care; patient expired on 09/17/2021.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary oedema, SARS-CoV-2 test positive
Clinical narrative: Patient arrived to Medical Center on 09/07/2021 for generalized weakness, chronic back pain, feeling tired and fatigued.  Additionally, patient reports having nonproductive cough, sore throat, mild shortness of breath for about 2-3 weeks. She reports being vaccinated for COVID-19 in March 202t with Pfizer. She was tested positive for COVID-19 on admission. Chest x-ray showed developing left lower lobe pneumonia. She received Zosyn in the ED however antibiotics were deferred after admission since her procalcitonin was negative, and no significant leukocytosis was noted. She was placed on nasal cannula at 2 L, and started on Decadron. Cardiology was consulted to recommend regarding her cardioprotective agents that she does not want to take.  CT chest PE protocol was deferred since her D-dimer was mildly elevated and considered within normal limit for her age. Patient did not qualify for remdesivir secondary to low creatinine clearance.  On 09/09/2021, her oxygen requirement went up, and she was requiring 8 L nasal cannula to maintain saturations low 90s at rest and was having dyspnea exertion with ambulation. Due to increased 02 requirement, she was changed from Decadron to IV Solu-Medrol frequently, and also started on Baricitinib. Chest x-ray from 09/09/2021 showed patchy infiltrates and/or edema slightly worsened therefore she was given a dose of Lasix x1. She was seen by Cardiology and setting was okay for her to not continue her Entresto if the patient wishes not to take the medication. Alternative, Cardiology recommended starting the patient on low-dose ACE-inhibitor therefore she was started on low-dose lisinopril.  Family decided on palliative care; patient expired on 09/17/2021.
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Aphthous ulcer, Oral pain
Clinical narrative: Painful canker sores found out on July 26th on left inside cheek Went to urgent care on 07/26/2022 and prescribed ibuprofen and triamcinolone Followed up with the PCP on 07/28/2022 As of 07/30/2022, canker sores still present (left and right inside cheek)
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Infertility, Pyrexia
Clinical narrative: Irritability; fever at 101°.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Deafness, Tinnitus
Clinical narrative: Tinnitus and hearing loss.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Brain oedema, Cardiac failure congestive, Chest X-ray abnormal, Computerised tomogram head abnormal
Clinical narrative: History of hypertension, diabetes, CDPD, lung cancer with recent finding of METS to the brain presented to Regional hospital on 02/06/2022 with worsening SOB. She was found to be in AFib RVR and was treated with Cardizem. Chest x-ray showed bibasilar interstitial and alveolar infiltrates, CHF versus pneumonia with: small bilateral allusions. She was treated with Lasix, started on Levaquin today. Unfortunately on 2/9 she fell. CT of the head without contrast showed right temporal lobe mass, decreased in size. and decreasing cerebral edema in the right temporal lobe, but no acute findings from the fall. Patient continued to decline and expired on 02/13/2022.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Death, Dyspnoea, Fall, General physical health deterioration, Intracranial mass
Clinical narrative: History of hypertension, diabetes, CDPD, lung cancer with recent finding of METS to the brain presented to Regional hospital on 02/06/2022 with worsening SOB. She was found to be in AFib RVR and was treated with Cardizem. Chest x-ray showed bibasilar interstitial and alveolar infiltrates, CHF versus pneumonia with: small bilateral allusions. She was treated with Lasix, started on Levaquin today. Unfortunately on 2/9 she fell. CT of the head without contrast showed right temporal lobe mass, decreased in size. and decreasing cerebral edema in the right temporal lobe, but no acute findings from the fall. Patient continued to decline and expired on 02/13/2022.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Lung infiltration, Pneumonia
Clinical narrative: History of hypertension, diabetes, CDPD, lung cancer with recent finding of METS to the brain presented to Regional hospital on 02/06/2022 with worsening SOB. She was found to be in AFib RVR and was treated with Cardizem. Chest x-ray showed bibasilar interstitial and alveolar infiltrates, CHF versus pneumonia with: small bilateral allusions. She was treated with Lasix, started on Levaquin today. Unfortunately on 2/9 she fell. CT of the head without contrast showed right temporal lobe mass, decreased in size. and decreasing cerebral edema in the right temporal lobe, but no acute findings from the fall. Patient continued to decline and expired on 02/13/2022.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Loss of consciousness
Clinical narrative: Fatigue. Breathing issues   Blackouts when  walked
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Pain, Pyrexia, Vomiting
Clinical narrative: Nausea and vomiting.  Tired and achy. Slight fever (100)
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, COVID-19, Death, Encephalopathy, General physical health deterioration
Clinical narrative: Patient presented to hospital on 06/08/2022 as a transfer from another Hospital for the management of Covid-19.  Patient developed progressive hypoxemic respiratory failure requiring hospitalization in the ICU.  She initially showed small improvement with dexamethasone and IV antibiotics, she ultimately developed worsened respiratory failure and oliguric renal failure.  Palliative care consulted.    On 06/21/2022 patient continue to decline and became unresponsive with worsened hypoxic respiratory failure.  MRI did not reveal acute change and encephalopathy was felt to be 2/2 respiratory failure.  Patient expired on 06/22/2022.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Intensive care, Magnetic resonance imaging normal, Respiratory failure, Unresponsive to stimuli
Clinical narrative: Patient presented to hospital on 06/08/2022 as a transfer from another Hospital for the management of Covid-19.  Patient developed progressive hypoxemic respiratory failure requiring hospitalization in the ICU.  She initially showed small improvement with dexamethasone and IV antibiotics, she ultimately developed worsened respiratory failure and oliguric renal failure.  Palliative care consulted.    On 06/21/2022 patient continue to decline and became unresponsive with worsened hypoxic respiratory failure.  MRI did not reveal acute change and encephalopathy was felt to be 2/2 respiratory failure.  Patient expired on 06/22/2022.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The BUD on this specific vaccine was past the due date when it was administered to this client.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The particular vaccine was given passed the BUD date to the client.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Antiphospholipid syndrome, Cardiac valve disease, Cardiolipin antibody positive, Echocardiogram abnormal, Endocarditis noninfective
Clinical narrative: The patient was admitted with worsening valvular heart disease. She appears to have nonbacterial thrombotic endocarditis. This, in turn, MAY be due to anticardiolpin Ab/antiphospolipid syndrome
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood loss anaemia, Cardiac valve disease, Cardiac valve vegetation, Colonoscopy, Computerised tomogram
Clinical narrative: The patient was admitted with worsening valvular heart disease. She appears to have nonbacterial thrombotic endocarditis. This, in turn, MAY be due to anticardiolpin Ab/antiphospolipid syndrome
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Haemoglobin, Haemorrhage, Peripheral swelling, Thrombosis, Weight
Clinical narrative: The patient was admitted with worsening valvular heart disease. She appears to have nonbacterial thrombotic endocarditis. This, in turn, MAY be due to anticardiolpin Ab/antiphospolipid syndrome
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Weight decreased
Clinical narrative: The patient was admitted with worsening valvular heart disease. She appears to have nonbacterial thrombotic endocarditis. This, in turn, MAY be due to anticardiolpin Ab/antiphospolipid syndrome
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood culture negative, COVID-19, COVID-19 pneumonia, Death
Clinical narrative: Patient history of renal transplant presneted to hospital on 02/23/2022 as a transfer with SOB, hypoxia in the setting of a recent  diagnosis of Covid-19.  Patient was admitted to ICU with acute hypoxemic respiratory failure 2/2 Covid PNA.  She required high flow nasal cannula, and progressed to needing BIPAP and then required intubation.  Patient was treated with steroids.  Blood cultures negative for any type of new bacterial infection.  Patient was treated empirically with antibiotics for most of her hospital stay as well and amphotericin given persistent shock and leukocytosis.  She required CRRT for worsening renal failure.  Patient continued to decline and was transitioned to comfort measures.  Patient expired on 03/12/2022.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Endotracheal intubation, General physical health deterioration, Haemofiltration, Hypoxia
Clinical narrative: Patient history of renal transplant presneted to hospital on 02/23/2022 as a transfer with SOB, hypoxia in the setting of a recent  diagnosis of Covid-19.  Patient was admitted to ICU with acute hypoxemic respiratory failure 2/2 Covid PNA.  She required high flow nasal cannula, and progressed to needing BIPAP and then required intubation.  Patient was treated with steroids.  Blood cultures negative for any type of new bacterial infection.  Patient was treated empirically with antibiotics for most of her hospital stay as well and amphotericin given persistent shock and leukocytosis.  She required CRRT for worsening renal failure.  Patient continued to decline and was transitioned to comfort measures.  Patient expired on 03/12/2022.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Intensive care, Leukocytosis, Positive airway pressure therapy, Renal failure, Shock
Clinical narrative: Patient history of renal transplant presneted to hospital on 02/23/2022 as a transfer with SOB, hypoxia in the setting of a recent  diagnosis of Covid-19.  Patient was admitted to ICU with acute hypoxemic respiratory failure 2/2 Covid PNA.  She required high flow nasal cannula, and progressed to needing BIPAP and then required intubation.  Patient was treated with steroids.  Blood cultures negative for any type of new bacterial infection.  Patient was treated empirically with antibiotics for most of her hospital stay as well and amphotericin given persistent shock and leukocytosis.  She required CRRT for worsening renal failure.  Patient continued to decline and was transitioned to comfort measures.  Patient expired on 03/12/2022.
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Energy increased, Feeling cold, Lethargy
Clinical narrative: Lethargic, then mild appeared to be getting a fever treated with Tylenol (7.5mg) at temp of 99.5at 3pm. Later around 8:30pm he started to shake and shiver saying he was cold, temperature check not fever level (98.6) used oximeter to check oxygen it indicated it was low of 77 and heart rate 91. Called nurse line to describe symptoms and she had use recheck temperature which had went up to 99.8 and heart rate of 160. She advised me to take him to ER. Within an hour. We took him to local hospital where at that time he had a temperature over 100 F. and an alarming heart rate of 150-160 for over an 1.5 time period. They have him ibuprofen and monitored heart rate. Today he is high energy (more than usual), no fever appetite, has not fully returned but was able to eat some. No appeared fever.
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, Pyrexia, Tremor
Clinical narrative: Lethargic, then mild appeared to be getting a fever treated with Tylenol (7.5mg) at temp of 99.5at 3pm. Later around 8:30pm he started to shake and shiver saying he was cold, temperature check not fever level (98.6) used oximeter to check oxygen it indicated it was low of 77 and heart rate 91. Called nurse line to describe symptoms and she had use recheck temperature which had went up to 99.8 and heart rate of 160. She advised me to take him to ER. Within an hour. We took him to local hospital where at that time he had a temperature over 100 F. and an alarming heart rate of 150-160 for over an 1.5 time period. They have him ibuprofen and monitored heart rate. Today he is high energy (more than usual), no fever appetite, has not fully returned but was able to eat some. No appeared fever.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: patient developed red, itchy circular rash 2 days after adminitration
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Eczema, Fatigue, Laboratory test normal, Mediastinal mass, Palpitations
Clinical narrative: August 24, 2021: Eczema on both feet. September 15, 2021: Started topical steroid cream. It took a month until both feet were cleared. December 6, 2021: Collapsed after a soccer match. Extremely fatigued. Heartrate was over 100 bpm until the next day. December 27, 2021: Complained about being more fatigued than usual with heart palpitations. Called his pediatrician. January 6, 2022: Office visit with pediatrician; ran tests; all came back normal. January 18, 2022: Cardiologist found an anterior mediastinal mass. January 19, 2022: Diagnosed with T-cell lymphoblastic lymphoma.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Precursor T-lymphoblastic lymphoma/leukaemia, Syncope
Clinical narrative: August 24, 2021: Eczema on both feet. September 15, 2021: Started topical steroid cream. It took a month until both feet were cleared. December 6, 2021: Collapsed after a soccer match. Extremely fatigued. Heartrate was over 100 bpm until the next day. December 27, 2021: Complained about being more fatigued than usual with heart palpitations. Called his pediatrician. January 6, 2022: Office visit with pediatrician; ran tests; all came back normal. January 18, 2022: Cardiologist found an anterior mediastinal mass. January 19, 2022: Diagnosed with T-cell lymphoblastic lymphoma.
Age: 55.0
Sex: F
Vaccine: COVID19, HEPAB, VARZOS
Symptoms: Headache, Influenza like illness, Neck pain
Clinical narrative: Patient states she has had flu-like symptoms since 7/6/2022 as well as head and neck pain since date of injection.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Aphasia, COVID-19, Gastrointestinal sounds abnormal, Hypokinesia, Oedema peripheral
Clinical narrative: Patient tested positive for Covid-19 on 06/30/2022 at the Hospital.  Patient was then accepted to hospice on 07/02/2022.  Patient arrived to hospital via ambulance from hospital accompanied by EMT's.  Patient presented nonverbal, decreased, negative purposeful movement, lungs with rales throughout, abdomen soft with hypoactive bowel sounds, skin hot to the touch and pale, left and right hands with 3+ edema, 4LNC of O2.  Patient presented actively dying.  Terminal diagnosis at facility was Covid-19.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Pallor, Rales, SARS-CoV-2 test positive, Skin warm, Terminal state
Clinical narrative: Patient tested positive for Covid-19 on 06/30/2022 at the Hospital.  Patient was then accepted to hospice on 07/02/2022.  Patient arrived to hospital via ambulance from hospital accompanied by EMT's.  Patient presented nonverbal, decreased, negative purposeful movement, lungs with rales throughout, abdomen soft with hypoactive bowel sounds, skin hot to the touch and pale, left and right hands with 3+ edema, 4LNC of O2.  Patient presented actively dying.  Terminal diagnosis at facility was Covid-19.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Headache, Injection site rash, Pain
Clinical narrative: After about 26 hours Fever of 102, chills, fatigue, aches, headache. All lasted for about 48 hours. On July 31 rash developed on left arm around injection site of pneumococcal vaccine that was administered the same time as shingles vax
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: After about 26 hours Fever of 102, chills, fatigue, aches, headache. All lasted for about 48 hours. On July 31 rash developed on left arm around injection site of pneumococcal vaccine that was administered the same time as shingles vax
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Eyelid disorder, Eyelid oedema, Swelling of eyelid
Clinical narrative: Adverse Event: Eyelid edema in right eye Signs: Eyelid appeared droopy Symptoms: Eyelid felt heavy and fuller to the touch Time Course: First noticed after waking up at 8 am. Did not worsen but remained swollen throughout the day, slowly improving. By the next morning, eyelid was back to normal. Treatment: Damp, warm cloth press for 10 minutes Outcome: Problem resolved within 24 hours
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder, Tinnitus
Clinical narrative: Day after injection of Moderna Covid Vaccine----a loud ringing in my ears woke me up from a very sound sleep.  I have had ringing in my ears since and it has not stopped.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Error: Dose in Series Given Too Early-
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Electromyogram, General physical health deterioration, Hypoaesthesia, Immediate post-injection reaction
Clinical narrative: After receiving the 1st dose on November 9th immediately started feeling numbness in the feet and leg weakness. This began a slow deterioration over two months that ended with complete paralysis from the waist down on January 2nd.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Lumbar puncture, Magnetic resonance imaging, Muscular weakness, Paralysis
Clinical narrative: After receiving the 1st dose on November 9th immediately started feeling numbness in the feet and leg weakness. This began a slow deterioration over two months that ended with complete paralysis from the waist down on January 2nd.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Dysarthria, Electromyogram, Magnetic resonance imaging, Movement disorder, Muscle disorder
Clinical narrative: Lost of facial movement  Slurred speech  Lost of muscle movement
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Amyotrophic lateral sclerosis, Blood test, Electromyogram, Magnetic resonance imaging
Clinical narrative: Diagnosed with ALS.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Anticoagulant therapy, Aortic valve incompetence, Atrial flutter, Atrioventricular block, Blood magnesium normal
Clinical narrative: Nausea and vomiting started on 7/24 (about 36 hr after vaccine).  Vomiting was relatively severe - 6-8 times during the day and night.  On 7/25, I noticed on my home heart monitor that my heart rate had markedly increased (from my normal ~40 bpm [I?m a runner] to ~130 bpm, and my blood pressure had dropped (from my normal ~120/70 to ~100/50).  On 7/26, I went to a  Urgent Care facility, and an EKG done there showed a distinct pattern of atrial flutter.  I was sent to an emergency room in an ambulance, and was successfully treated by an ablation procedure (on my right atrium) on 7/27.  I went home on 7/28, initiated anti-coagulant treatment with Eliquis,  and have had no further problems.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Blood pressure decreased, Cardiac ablation, Cardiac monitoring abnormal, Differential white blood cell count abnormal, Echocardiogram abnormal
Clinical narrative: Nausea and vomiting started on 7/24 (about 36 hr after vaccine).  Vomiting was relatively severe - 6-8 times during the day and night.  On 7/25, I noticed on my home heart monitor that my heart rate had markedly increased (from my normal ~40 bpm [I?m a runner] to ~130 bpm, and my blood pressure had dropped (from my normal ~120/70 to ~100/50).  On 7/26, I went to a  Urgent Care facility, and an EKG done there showed a distinct pattern of atrial flutter.  I was sent to an emergency room in an ambulance, and was successfully treated by an ablation procedure (on my right atrium) on 7/27.  I went home on 7/28, initiated anti-coagulant treatment with Eliquis,  and have had no further problems.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Electrocardiogram abnormal, Full blood count abnormal, HIV test negative, Haematocrit decreased, Heart rate increased
Clinical narrative: Nausea and vomiting started on 7/24 (about 36 hr after vaccine).  Vomiting was relatively severe - 6-8 times during the day and night.  On 7/25, I noticed on my home heart monitor that my heart rate had markedly increased (from my normal ~40 bpm [I?m a runner] to ~130 bpm, and my blood pressure had dropped (from my normal ~120/70 to ~100/50).  On 7/26, I went to a  Urgent Care facility, and an EKG done there showed a distinct pattern of atrial flutter.  I was sent to an emergency room in an ambulance, and was successfully treated by an ablation procedure (on my right atrium) on 7/27.  I went home on 7/28, initiated anti-coagulant treatment with Eliquis,  and have had no further problems.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Hepatitis C test negative, Metabolic function test normal, Nausea, Red blood cell count decreased, SARS-CoV-2 test negative
Clinical narrative: Nausea and vomiting started on 7/24 (about 36 hr after vaccine).  Vomiting was relatively severe - 6-8 times during the day and night.  On 7/25, I noticed on my home heart monitor that my heart rate had markedly increased (from my normal ~40 bpm [I?m a runner] to ~130 bpm, and my blood pressure had dropped (from my normal ~120/70 to ~100/50).  On 7/26, I went to a  Urgent Care facility, and an EKG done there showed a distinct pattern of atrial flutter.  I was sent to an emergency room in an ambulance, and was successfully treated by an ablation procedure (on my right atrium) on 7/27.  I went home on 7/28, initiated anti-coagulant treatment with Eliquis,  and have had no further problems.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Vomiting
Clinical narrative: Nausea and vomiting started on 7/24 (about 36 hr after vaccine).  Vomiting was relatively severe - 6-8 times during the day and night.  On 7/25, I noticed on my home heart monitor that my heart rate had markedly increased (from my normal ~40 bpm [I?m a runner] to ~130 bpm, and my blood pressure had dropped (from my normal ~120/70 to ~100/50).  On 7/26, I went to a  Urgent Care facility, and an EKG done there showed a distinct pattern of atrial flutter.  I was sent to an emergency room in an ambulance, and was successfully treated by an ablation procedure (on my right atrium) on 7/27.  I went home on 7/28, initiated anti-coagulant treatment with Eliquis,  and have had no further problems.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Muscle rigidity, Muscle spasms, Muscle tightness, Musculoskeletal stiffness
Clinical narrative: patient experienced flushing, and hand muscle cramps and rigity also experienced tightness in calf muscles. After patient sat down for about 15 minutes minutes and hydrated, the patient felt better and the muscle stiffness went away except for soreness.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: patient experienced flushing, and hand muscle cramps and rigity also experienced tightness in calf muscles. After patient sat down for about 15 minutes minutes and hydrated, the patient felt better and the muscle stiffness went away except for soreness.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: The patient is 5 years old.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Eight days after receiving the vaccine I began to itch on my upper legs, trunk and chest. The itching became very intense my skin had a rash in some places. The itching literally was worse than anything I had ever experienced. Though I was given vistaril, the only thing that would give me the smallest relief was the over the counter calamine spray. The itching finally began to subside about 9 days after it began. The only thing I could contribute this to was the Covid vaccination because it was the only thing different in my routine.
Age: 94.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Laboratory test, Pain in extremity, Pallor, Thrombectomy, Thrombosis
Clinical narrative: Massive pain in right leg, significant pallor. Taken to ER, over 900mL in blood clots removed in two procedures.
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Cold sweat, Cyanosis, Dyspnoea, Heart rate increased, Hypotonia
Clinical narrative: Life threatening episode requiring emergency transport: clammy skin and vomiting leading (8 minutes) to difficulty breathing (wheezing and flared nostrils-2 minutes). Turned blue, limp, non-responsive. Fully stopped breathing for two minutes.  After several chest compressions started breathing again, rolled over, and threw up.
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory arrest, Resuscitation, Unresponsive to stimuli, Vomiting, Wheezing
Clinical narrative: Life threatening episode requiring emergency transport: clammy skin and vomiting leading (8 minutes) to difficulty breathing (wheezing and flared nostrils-2 minutes). Turned blue, limp, non-responsive. Fully stopped breathing for two minutes.  After several chest compressions started breathing again, rolled over, and threw up.
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: Life threatening episode requiring emergency transport: clammy skin and vomiting leading (8 minutes) to difficulty breathing (wheezing and flared nostrils-2 minutes). Turned blue, limp, non-responsive. Fully stopped breathing for two minutes.  After several chest compressions started breathing again, rolled over, and threw up.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, Chest X-ray normal, Fall, Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: Patient received moderna vaccine on 2/5/21, 3/9/21 and 10/27/21. Presented to ER on 7/17/22 and found to be COVID positive. Came to ER for falls. Was asymptomatic for COVID19. Discharged on 7/28/22
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea
Clinical narrative: Patient had trouble breathing and had sharp chest pains
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Presyncope
Clinical narrative: Pt had a vasovagal response to her Moderna 2nd booster.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Atypical pneumonia, Bronchitis, COVID-19, Chest X-ray abnormal
Clinical narrative: Patient received moderna vaccine on 2/4/21, 3/4/21, and 10/29/21. Presented to ER on 7/25/22 and found to be COVID positive. admitted on 7/25/2022 for COVID infection, hypoxemic respiratory failure, metabolic encephalopathy.              Sepsis present on admission, altered mental status, tachy, hypoxic with mild lactic acidosis.  CT chest no pneumonia however showing bronchitis, V/Q low probability of PE.              Patient was vaccinated against COVID. Was on dexamethasone and remdesivir.  AKI on CKD 3B, received gentle IV fluid given H/O diastolic CHF.  Lasix remain on hold.               Clinically improving, maintaining saturation on room air.  Neck exam medicine, remdesivir discontinued. Patient is medically stable to be discharge Skilled Nursing Facility on 7/28/22 on doxycycline
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic kidney disease, Computerised tomogram thorax abnormal, Hypoxia, Lactic acidosis, Lung opacity
Clinical narrative: Patient received moderna vaccine on 2/4/21, 3/4/21, and 10/29/21. Presented to ER on 7/25/22 and found to be COVID positive. admitted on 7/25/2022 for COVID infection, hypoxemic respiratory failure, metabolic encephalopathy.              Sepsis present on admission, altered mental status, tachy, hypoxic with mild lactic acidosis.  CT chest no pneumonia however showing bronchitis, V/Q low probability of PE.              Patient was vaccinated against COVID. Was on dexamethasone and remdesivir.  AKI on CKD 3B, received gentle IV fluid given H/O diastolic CHF.  Lasix remain on hold.               Clinically improving, maintaining saturation on room air.  Neck exam medicine, remdesivir discontinued. Patient is medically stable to be discharge Skilled Nursing Facility on 7/28/22 on doxycycline
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Mental status changes, Metabolic encephalopathy, Respiratory failure, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Patient received moderna vaccine on 2/4/21, 3/4/21, and 10/29/21. Presented to ER on 7/25/22 and found to be COVID positive. admitted on 7/25/2022 for COVID infection, hypoxemic respiratory failure, metabolic encephalopathy.              Sepsis present on admission, altered mental status, tachy, hypoxic with mild lactic acidosis.  CT chest no pneumonia however showing bronchitis, V/Q low probability of PE.              Patient was vaccinated against COVID. Was on dexamethasone and remdesivir.  AKI on CKD 3B, received gentle IV fluid given H/O diastolic CHF.  Lasix remain on hold.               Clinically improving, maintaining saturation on room air.  Neck exam medicine, remdesivir discontinued. Patient is medically stable to be discharge Skilled Nursing Facility on 7/28/22 on doxycycline
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: Patient received moderna vaccine on 2/4/21, 3/4/21, and 10/29/21. Presented to ER on 7/25/22 and found to be COVID positive. admitted on 7/25/2022 for COVID infection, hypoxemic respiratory failure, metabolic encephalopathy.              Sepsis present on admission, altered mental status, tachy, hypoxic with mild lactic acidosis.  CT chest no pneumonia however showing bronchitis, V/Q low probability of PE.              Patient was vaccinated against COVID. Was on dexamethasone and remdesivir.  AKI on CKD 3B, received gentle IV fluid given H/O diastolic CHF.  Lasix remain on hold.               Clinically improving, maintaining saturation on room air.  Neck exam medicine, remdesivir discontinued. Patient is medically stable to be discharge Skilled Nursing Facility on 7/28/22 on doxycycline
Age: 40.0
Sex: F
Vaccine: SMALLMNK
Symptoms: Chills, Exposure to communicable disease, Headache, Impaired work ability, Influenza A virus test negative
Clinical narrative: Fevers, chills, headaches, body aches 24-48 hours after; sore throat 48-96 hours after; pink papular rash on upper chest, arms, neck, and face 113 hours after administration. (NOT hives.) Hard, red, tender, itchy, indurated area size of deck of cards on left arm injection site, ongoing 9 days after injection. Because of COVID protocols and mpx exposure, I was tested for Covid PCR x 2, viral respiratory panel x 1, swabbed for MPX (no result, 96+ hours after swab), and kept out of work for an entire week so far.   1 week of work missed as a nurse practitioner in a primary care clinic with serious staffing difficulties already, during a public health emergency. Isolation away from my two young children, distressing to both the children and the parent.   There's no data on papular rash after Jynneos. Does it occur? Was this a vaccine reaction? Was this unrelated?  How are MPX-exposed individuals getting PEP vaccination supposed to distinguish between vaccine reaction vs acute illness?  What are the healthcare staffing consequences of these reactions? Should people be kept out of work?   Should MPX swabs of HCWs be expedited? If negative, is that even enough to clear to return to work or does the HCW have to wait until all symptoms have fully resolved?   Can symptoms be treated with antihistamines or topicals or any other measures to resolve them faster to allow return to essential work? If these treatments are effective, does that mean it was vax related and not infection?
Age: 40.0
Sex: F
Vaccine: SMALLMNK
Symptoms: Influenza B virus test, Injection site erythema, Injection site induration, Injection site pain, Injection site pruritus
Clinical narrative: Fevers, chills, headaches, body aches 24-48 hours after; sore throat 48-96 hours after; pink papular rash on upper chest, arms, neck, and face 113 hours after administration. (NOT hives.) Hard, red, tender, itchy, indurated area size of deck of cards on left arm injection site, ongoing 9 days after injection. Because of COVID protocols and mpx exposure, I was tested for Covid PCR x 2, viral respiratory panel x 1, swabbed for MPX (no result, 96+ hours after swab), and kept out of work for an entire week so far.   1 week of work missed as a nurse practitioner in a primary care clinic with serious staffing difficulties already, during a public health emergency. Isolation away from my two young children, distressing to both the children and the parent.   There's no data on papular rash after Jynneos. Does it occur? Was this a vaccine reaction? Was this unrelated?  How are MPX-exposed individuals getting PEP vaccination supposed to distinguish between vaccine reaction vs acute illness?  What are the healthcare staffing consequences of these reactions? Should people be kept out of work?   Should MPX swabs of HCWs be expedited? If negative, is that even enough to clear to return to work or does the HCW have to wait until all symptoms have fully resolved?   Can symptoms be treated with antihistamines or topicals or any other measures to resolve them faster to allow return to essential work? If these treatments are effective, does that mean it was vax related and not infection?
Age: 40.0
Sex: F
Vaccine: SMALLMNK
Symptoms: Oropharyngeal pain, Pain, Pyrexia, Rash, Rash erythematous
Clinical narrative: Fevers, chills, headaches, body aches 24-48 hours after; sore throat 48-96 hours after; pink papular rash on upper chest, arms, neck, and face 113 hours after administration. (NOT hives.) Hard, red, tender, itchy, indurated area size of deck of cards on left arm injection site, ongoing 9 days after injection. Because of COVID protocols and mpx exposure, I was tested for Covid PCR x 2, viral respiratory panel x 1, swabbed for MPX (no result, 96+ hours after swab), and kept out of work for an entire week so far.   1 week of work missed as a nurse practitioner in a primary care clinic with serious staffing difficulties already, during a public health emergency. Isolation away from my two young children, distressing to both the children and the parent.   There's no data on papular rash after Jynneos. Does it occur? Was this a vaccine reaction? Was this unrelated?  How are MPX-exposed individuals getting PEP vaccination supposed to distinguish between vaccine reaction vs acute illness?  What are the healthcare staffing consequences of these reactions? Should people be kept out of work?   Should MPX swabs of HCWs be expedited? If negative, is that even enough to clear to return to work or does the HCW have to wait until all symptoms have fully resolved?   Can symptoms be treated with antihistamines or topicals or any other measures to resolve them faster to allow return to essential work? If these treatments are effective, does that mean it was vax related and not infection?
Age: 40.0
Sex: F
Vaccine: SMALLMNK
Symptoms: Rash papular, Respiratory syncytial virus test negative, Respiratory viral panel, SARS-CoV-2 test negative, Skin culture
Clinical narrative: Fevers, chills, headaches, body aches 24-48 hours after; sore throat 48-96 hours after; pink papular rash on upper chest, arms, neck, and face 113 hours after administration. (NOT hives.) Hard, red, tender, itchy, indurated area size of deck of cards on left arm injection site, ongoing 9 days after injection. Because of COVID protocols and mpx exposure, I was tested for Covid PCR x 2, viral respiratory panel x 1, swabbed for MPX (no result, 96+ hours after swab), and kept out of work for an entire week so far.   1 week of work missed as a nurse practitioner in a primary care clinic with serious staffing difficulties already, during a public health emergency. Isolation away from my two young children, distressing to both the children and the parent.   There's no data on papular rash after Jynneos. Does it occur? Was this a vaccine reaction? Was this unrelated?  How are MPX-exposed individuals getting PEP vaccination supposed to distinguish between vaccine reaction vs acute illness?  What are the healthcare staffing consequences of these reactions? Should people be kept out of work?   Should MPX swabs of HCWs be expedited? If negative, is that even enough to clear to return to work or does the HCW have to wait until all symptoms have fully resolved?   Can symptoms be treated with antihistamines or topicals or any other measures to resolve them faster to allow return to essential work? If these treatments are effective, does that mean it was vax related and not infection?
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, COVID-19, Haemorrhage, SARS-CoV-2 test positive
Clinical narrative: Patient received moderna vaccine on 1/20/21, 2/17/21, 9/16/21 and 4/21/22. Unknown lot numbers. Presented to ER on 7/25/22. Was admitted for bleed. Asymptomatic COVID19.  COVID positive on 7/16/22
Age: 87.0
Sex: F
Vaccine: PPV
Symptoms: Arthralgia, Gait disturbance
Clinical narrative: patient reported pain in her hips with direct onset at the time of vaccination, trouble walking. called EMS, took her BP which was 207/110 mmHg. Upon their arrival, her BP had come down a bit, and she reported no pain and was able to walk but because of her BP they wanted her to been taken into the hospital.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Colitis, Gallbladder disorder, Loss of consciousness, Vomiting
Clinical narrative: Vaccine administered at 4pm. Patient sat in waiting area for about 20 minutes and didn't express any issues when I was checking on her and her other family members that were vaccinated. At about 4:20pm she and the other family members headed towards the front of our store. She was accompanied by her daughter. At about 4:30-4:40pm a customer yelled into the pharmacy to dial 911, because a woman was starting to lose consciousness. When EMS arrived 4-5 mins. later, they left, because the patient's daughter said she didn't want her transported to the hospital. After about 10-15 minutes, I was informed that patient was regressing and patient's daughter called 911 this time. When EMS came 2nd time, patient was transported to local hospital for follow-up. I followed up with patient's daughter next day via phone (07/31/2022). She informed me that her mom arrived at the ER and was vomiting so they were suspecting gall bladder issues our colitis. They did not think the vaccine caused her reactions, because she was feeling tired/dizzy all week before and her heart rate was extremely low despite having a pacemaker.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, X-ray
Clinical narrative: pain in right wrist, especially when lifting anything heavy or bending the hand backwards. This began sometime in April 2022, I don't remember exactly. I listed this on the V-Safe check-in to be thorough.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebral arteriovenous malformation haemorrhagic
Clinical narrative: Brain AVM rupture due to second Covid vaccine dose of the Moderna vaccine
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pharyngeal ulceration, Skin warm, Tongue ulceration
Clinical narrative: Severe red swollen hot arm  Sores on tongue and in throat
Age: 1.25
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Induration, Lymphadenopathy, Ultrasound scan, White blood cell count increased
Clinical narrative: Enlarged and hard lymph node just under/on right jaw bone. Vaccine was given in left thigh
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Vomiting
Clinical narrative: Woke up with a severe migraine (so bad it induced vomiting most of day).  Probably began about 12-14 hours after the injection.  Lasted into evening.  One of my most severe migraines and definitely the longest lasting
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Delivery, Exposure during pregnancy
Clinical narrative: Due date 30.04.2022  Delivery was on an earlier date wight 3.190kg Syndactyly all fingers in right hand.  Smaller hand and thinner forearm
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Client (DOB: 8/22/2018) received second dose of Moderna 6 months to 5 years COVID vaccine lot # AR9237B  today in left arm at 11:18 am. At 11:40 am client stated his "toe was itchy." PHN and RN approached client in the observation area, sitting upright in the chair next to his father. PHN lifted client's shirt to observe skin. No rashes or hives observed on trunk, chest, neck, arms, legs, feet, or toes. Skin dry and appropriate to Ethnicity. Client's father reported a history of eczema and peanut allergies. Client has his own epi-pen and reported having rash on chest, shoulders, and back and threw up when ate peanut butter as an infant. Client not taking any medications. Vitals taken at 11:43 am, when client reported "itchiness is gone: "BP 90/60, HR 106 bpm, SPO2 97%, RR23. No difficulty breathing noted, client talking and playing on IPAD. At 11:49 am client confirmed itchiness had not returned. PHN educated father to remain in observation for 30 more minutes to monitor. At 11:59 am PHN called Clinical Project Coordinator. Per Coordinator, if itchiness returns at all, to call 9-1-1 and continue to monitor for 30 minutes. At 12:06 pm, PHN observed no rashes on skin and client denied itching. PHN educated father to follow up with primary care provider in 24 hours, and reviewed signs and symptoms of an emergency and when to call 9-1-1. Client left with father at 12:18 pm with steady gait, no concerns.
Age: 57.0
Sex: M
Vaccine: UNK
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient received second dose of Jynneos monkeypox vaccine 7 days before second dose was due. No immediate adverse outcome while in vaccination clinic.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Migraine
Clinical narrative: migraine, started  about 15 -17 hours after vaccine.  I have not had a migraine since the last COVID booster (moderna) in December 2021.  Lasted all day.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Contusion, Fatigue, Immunoglobulin therapy, Laboratory test
Clinical narrative: Thrombocytopenia resulting in hospitalization. Symptoms weakness, fatigue, bruising and petechiae. Treatment dexamethasone and IV immunoglobulin therapy.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Petechiae, Platelet count decreased, Thrombocytopenia, Ultrasound scan
Clinical narrative: Thrombocytopenia resulting in hospitalization. Symptoms weakness, fatigue, bruising and petechiae. Treatment dexamethasone and IV immunoglobulin therapy.
Age: 53.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Blister, Injection site erythema, Injection site pain, Injection site swelling, Rash erythematous
Clinical narrative: Severe redness, pain, and swelling at injection site. Raised, blistered, red spots on same arm but not near injection site.
Age: 53.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Rash papular
Clinical narrative: Severe redness, pain, and swelling at injection site. Raised, blistered, red spots on same arm but not near injection site.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Facial pain, Neuralgia, Pain
Clinical narrative: Rt side facial sharp shooting nerve pain. Started on 12/17/2021. and ended 1/7/2022
Age: 37.0
Sex: F
Vaccine: UNK
Symptoms: Anaemia, Heavy menstrual bleeding, Uterine leiomyoma
Clinical narrative: After a few months of getting my first dose of Pfizer's COVID vaccine, I started to have VERY heavy period bleedings...fibroids have now developed....and now I'm currently being treated for the condition of Menorrhagia. My period bleeding is so heavy each month that my gyno has warned me that I run the risks of being admitted to the ER if I'm loosing too much blood. It's very scary...has never been this heavy and I've also become anemic (now am taking Iron pills to counter the symptoms). As I've spoken to other females (in their later 30's to mid 40's) who have also experienced heavy period bleedings (but my situation is probably one of the worst considering I need medical treatment), I kindly implore the medical community to research and look into this as the adverse affect it's having on some of us females suffering from very heavy menstrual cycles (and mine which I probably will need surgery for). It's made me question getting the 2nd booster since I'm nervous about the amount of continuing blood loss.